FDA panel recommends vaccine for children 5 to 11

Clinical trial data for the COVID-19 vaccine for children ages 5 to 11 shows no cases of rare myocarditis and an overall 91% effectiveness against symptomatic infections.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting